Financials
- Market Capitalization 534.24 M
- Employee 246
- Founded 2013
- CEO N/A
- Website www.arvinas.com
- Headquarter Delaware, United States
- FIGI BBG00LW7YK82
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.33
ratio cours/chiffre d'affaires
8.43
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2839 | IMMX Immix Biopharma, Inc. - Common Stock | 10.53 USD | -1.40% | -4.27% | +23.88% | +273.40% | 572.95 M USD | ||
| 2850 | DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 9.02 USD | -0.33% | -1.96% | +10.95% | +1.58% | 562.17 M USD | ||
| 2911 | NVCT Nuvectis Pharma, Inc. - Common Stock | 19.59 USD | +7.11% | +4.48% | +74.29% | +139.19% | 519.64 M USD | ||
| 2914 | ZURA Zura Bio Limited - Class A Ordinary shares | 5.39 USD | +6.52% | -1.82% | +46.87% | +308.33% | 512.04 M USD |